EcoDrugPlus

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSGACG00000020547
Gene Symbol: ALOX5AP
1 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSGACG00000000737
Gene Symbol: AVPR1A
2 Cross references
186 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSGACG00000003589
Gene Symbol: AVPR1AB
2 Cross references
203 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSGACG00000010636
Gene Symbol: AVPR2
2 Cross references
166 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSGACG00000008681
Gene Symbol: AVPR2
2 Cross references
210 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSGACG00000006354
Gene Symbol: AURKA
1 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSGACG00000016381
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSGACG00000006022
Gene Symbol: BACE1
1 Cross references
221 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSGACG00000010583
Gene Symbol: BDKRB1
1 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSGACG00000010586
Gene Symbol: BDKRB2
2 Cross references
182 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSGACG00000010585
Gene Symbol: BDKRB2
2 Cross references
151 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSGACG00000010581
Gene Symbol: BDKRB2
1 Cross references
241 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).